Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ACTRN12626000233325) titled 'Food Effect Study of ACE-2223-1 Solid Formulation in Healthy Adult Participants (Part D)' on Feb. 24.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Primary Sponsor: Acelot, Inc.
Condition:
Amyotrophic Lateral Sclerosis (ALS)
Amyotrophic Lateral Sclerosis (ALS)
Neurological - Neurodegenerative diseases
Intervention:
Part D (Food Effect, FE) will consist of an open-label, randomised sequence, 2-way crossover investigation to evaluate the effect of food on the pharmacokinetics of the ACE-2223-1 solid formulation. The dose level for this assessment will...